Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock
Open Access
- 4 January 2023
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33372
Abstract
The extracorporeal membrane oxygenation (ECMO) procedure aids in the provision of prolonged cardiopulmonary support, whereas the Impella device (Abiomed, Danvers, MA) is a ventricular assist device that maintains circulation by pumping blood into the aorta from the left ventricle. Blood is circulated in parallel with the heart by Impella. It draws blood straight into the aorta from the left ventricle, hence preserving the physiological flow. ECMO bypasses the left atrium and the left ventricle, and the end consequence is a non-physiological flow. In this article, we conducted a detailed analysis of various publications in the literature and examined various modalities pertaining to the use of ECMO and Impella for cardiogenic shocks, such as efficacy, clinical outcomes, cost-effectiveness, device-related complications, and limitations. The Impella completely unloads the left ventricle, thereby significantly reducing the effort of the heart. Comparatively, ECMO only stabilizes a patient with cardiogenic shock for a short stretch of time and does not lessen the efforts of the left ventricle ("unload" it). In the acute setting, both devices reduced left ventricular end-diastolic pressure and provided adequate hemodynamic support. By comparing patients on Impella to those receiving ECMO, it was found that patients on Impella were associated with better clinical results, quicker recovery, limited complications, and reduced healthcare costs; however, there is a lack of conclusive studies performed demonstrating the reduction in long-term mortality rates. Considering the effectiveness of given modalities and taking into account the various studies described in the literature, Impella has reported better clinical outcomes although more clinical trials are needed for establishing the effectiveness of these interventional approaches in revascularization in cardiogenic shock.Keywords
This publication has 96 references indexed in Scilit:
- Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current eraThe Journal of Heart and Lung Transplantation, 2013
- Infections occurring during extracorporeal membrane oxygenation use in adult patientsThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Microembolic signals and strategy to prevent gas embolism during extracorporeal membrane oxygenationJournal of Cardiothoracic Surgery, 2010
- Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestineLaboratory Investigation, 2009
- Safety and Feasibility of Elective High-Risk Percutaneous Coronary Intervention Procedures With Left Ventricular Support of the Impella Recover LP 2.5The American Journal of Cardiology, 2006
- Serial Plasma Concentrations of Atrial Natriuretic Peptide, Plasma Renin Activity, Aldosterone, and Antidiuretic Hormone in Neonates on Extracorporeal Membrane OxygenationASAIO Journal, 2002
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic ShockNew England Journal of Medicine, 1999
- Nosocomial Infections in Adult Patients Undergoing Extracorporeal Membrane OxygenationClinical Infectious Diseases, 1999
- Cardiogenic ShockNew England Journal of Medicine, 1994
- Letter to the editor: Changes in fibrinolytic factors in newborns during extracorporeal membrane oxygenation (ECMO)American Journal of Hematology, 1991